aTyr Pharma (ATYR) Earnings Analysis
aTyr Pharma (ATYR) has no confirmed upcoming earnings date. Last quarter (2026-05-15) it beat with EPS -0.11 USD vs -0.16 USD est (+31.3%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -0.67.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ATYR next report earnings?
No confirmed upcoming earnings date is currently scheduled for ATYR. This page updates as the calendar is published.
ATYR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.11 USD | -0.16 USD | +31.3% | Beat |
| 2026-03-05 | -0.14 USD | -0.18 USD | +22.2% | Beat |
| 2025-11-06 | -0.26 USD | -0.2 USD | -30% | Miss |
| 2025-08-07 | -0.22 USD | -0.18 USD | -22.2% | Miss |
| 2025-03-13 | -0.18 USD | -0.23 USD | +21.7% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
ATYR valuation and analyst view
| Trailing P/E | -0.67 |
|---|---|
| Trailing EPS | -0.71426 USD |
| Price / book | 0.82 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Hold (3 buy / 7 hold / 0 sell) |
| Avg price target | 5.13 USD |
Related research pages
Frequently asked questions
When is aTyr Pharma (ATYR)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ATYR. This page updates as the calendar is published.
Did ATYR beat earnings last quarter?
In its 2026-05-15 report, ATYR posted EPS of -0.11 USD versus a -0.16 USD estimate — a beat of 31.3%.
What is ATYR's earnings track record?
Over the last 5 reported quarters with consensus data, ATYR beat estimates 3 times (60%).
What is ATYR's current P/E ratio and EPS?
ATYR trades at a trailing P/E of -0.67 on trailing EPS of -0.7142621169699404 USD.
What do analysts rate ATYR?
Analyst consensus is "Hold" across 10 ratings (0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 5.13 USD.